T1D
13
7
7
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (13)
Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
Pre-Exercise Whey and Pea Protein in Adolescents With Type 1 Diabetes
Type 1 Diabetes Extension Study
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
Simultaneous Measurement and Responsive Treatment - Part 2
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Evaluation of a Biopsychosocial System
Validation of a Computerised Adaptive Test for Measuring Caregiver Well-being
Tocilizumab (TCZ) in New-onset Type 1 Diabetes